Yes. Neopharmed Gentili is owned by private equity investor Ardian.
Neopharmed Gentili is headquartered in Milan, Italy.
Neopharmed Gentili is a life science company.
Neopharmed Gentili was founded in 2011.
Via San Giuseppe, Cottolengo 15,
Milan,
20143
Italy,
+39 0289132600
www.neogen.it
Neopharmed Gentili is an Italian pharmaceutical group focused on the research, development, production, and distribution of medicines in many therapeutic areas such as vascular and cardio-metabolic areas, pneumatological areas, antibiotics, OTCs, and supplements. Neopharmed Gentili was founded in 2011 and is based in Milan, Italy.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.2/yr) | # | 1 | - | - | - | - | 1 | 2 |
| vol | $264M | $264M | ||||||
| Sell (0.0/yr) | # | - | - | - | - | - | - | 0 |
| 2 | ||||||||
| Financial | Deals |
|---|---|
|
Centerview Partners |
1 |
| Legal | Deals |
|---|---|
|
White & Case |
1 |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
